FDA Inspection 1020544 — Hubei Danao Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei Danao Pharmaceutical Co., Ltd. on August 4, 2017 in Shiyan. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 4, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shiyan (China)